Care Global Pharmacy

Product Name: Mounjaro 2.5mg/5mg Solution for Injection

Brand Name: Mounjaro, Tirzepatide, Lyumjev (Note: Lyumjev is primarily insulin lispro, but associated with Eli Lilly’s diabetes care portfolio)

Composition: Tirzepatide (2.5mg/5mg)

Manufacturer/Marketer: Eli Lilly and Company India Pvt Ltd

Packaging: To be provided (specify packaging details if available)

Treatment: Type 2 diabetes mellitus (to improve glycemic control)

Product Description: Mounjaro Solution for Injection contains Tirzepatide, a novel dual GIP and GLP-1 receptor agonist used for the management of type 2 diabetes. It helps regulate blood sugar levels by enhancing insulin release, reducing glucagon secretion, and slowing gastric emptying, leading to improved glycemic control